Vanguard High Dividend Yield ETF vs DENTSPLY SIRONA Inc — how do they compare? Vanguard High Dividend Yield ETF trades at $158.5 (market cap $100.80B), while DENTSPLY SIRONA Inc trades at $8.67 (market cap $1.70B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 59.3× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard High Dividend Yield ETF for 138 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| VYM | XRAY | |
|---|---|---|
Market Cap | $100.80B | $1.70B |
Volume | 993,696 | 4,220,050 |
52-Week High | $167.03 | $14.68 |
52-Week Low | $137.47 | $8.52 |
Typical Hold Time | 138 Days | 72 Days |
Sector | — | Health |
Enterprise Value | — | $3.78B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
VYM trades at $157.45, down 0.58% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF's 2.42% yield provides consistent income, though recent articles highlight performance comparisons with peers like SCHD and IDV. Support and resistance levels cluster tightly around $157-158, indicating potential for near-term price consolidation.
The outlook remains cautious as VYM faces competitive pressure from higher-yielding alternatives and concerns about dividend sustainability in its holdings. While diversification and low costs are strengths, investors should weigh the trade-offs between yield consistency and total return potential in the current market environment.
DENTSPLY SIRONA (XRAY) trades at $8.54, near a 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenues and negative net income margins. Recent news highlights institutional stake increases and ongoing turnaround efforts amid sales weakness in dental segments.
The outlook remains challenging due to persistent profitability issues and high debt, though analyst consensus suggests upside to a $13.40 price target. Key risks include margin pressure and competitive threats, while potential catalysts include successful restructuring and digital dentistry growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →